Analystreport

Journey Medical Co. (NASDAQ: DERM) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $9.00 price target on the stock.

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com